BCG
BMY icon

Breakwater Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Breakwater Capital Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
3,651
-507
-12% -$29.1K 0.03% 368
2026
Q1 		$252K Buy
+4,158
New +$242K 0.03% 325
2023
Q4 		– Sell
-7,992
Closed -$410K – 248
2023
Q3 		$410K Sell
7,992
-2,628
-25% -$161K 0.14% 138
2023
Q2 		$679K Sell
10,620
-1,591
-13% -$107K 0.25% 89
2023
Q1 		$846K Buy
12,211
+913
+8% +$64.4K 0.36% 73
2022
Q4 		$813K Buy
+11,298
New +$852K 0.43% 67

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Breakwater Capital Group's BMY Position: Q2 2026 in Review

Breakwater Capital Group reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, selling an estimated $29.1K and leaving 3,651 shares worth $210K. The position accounts for 0.03% of the portfolio, ranked #368.

Breakwater Capital Group first reported a position in BMY in Q4 2022 and has held it in 6 quarters since. The position peaked at $846K in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Breakwater Capital Group held 3,651 shares of Bristol-Myers Squibb worth $210K as of Q2 2026.
  • Breakwater Capital Group sold 507 Bristol-Myers Squibb shares in Q2 2026, an estimated $29.1K.
  • Bristol-Myers Squibb made up 0.03% of Breakwater Capital Group's portfolio in Q2 2026, its #368 holding.
  • Breakwater Capital Group first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 6 quarters since.
  • Breakwater Capital Group's Bristol-Myers Squibb position peaked at $846K in Q1 2023.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Breakwater Capital Group's 13F filing for Q2 2026, filed 8 Jul 2026.